Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Missouri for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Missouri only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Missouri (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Patrick Jensen (NPI 1831657527)

Field	Value
Entity Type	Individual
Organization	Patrick Jensen
Address	2801 Nw Castle Dr
City	Blue Springs
State	MO
ZIP	64015
Taxonomy	Family Nurse Practitioner
NPI Enumerated	March 12, 2019

Payer Source	Total Paid
Medicare	$1.8M
Medicaid	$0

Key Findings

PATRICK JENSEN is listed as a Family Nurse Practitioner in BLUE SPRINGS, MO and has an NPI enumeration date of 2019-03-12 (~7 years ago). The provider’s billing record is heavily weighted toward Medicare activity, with the provider reporting $1.8M in lifetime Medicare revenue and no Medicaid billing on file. This tenure and single‑payer footprint frame the subsequent patterns in specialty drug and infusion billing.

The provider is effectively single‑payer in scope: Medicare accounts for $1.8M of lifetime revenue while Medicaid is listed as none (no Medicaid billing on file). Analysts should treat this profile as Medicare‑centric when assessing revenue risk, network access and reimbursement exposure because there is no Medicaid revenue to diversify payer mix.

Revenue concentration is high at the code level: the precomputed top three Medicare codes (J3245, J2357, J3380) account for 61.7% of this provider's total Medicare revenue. Individually those codes are J3245 $451K (24.8%), J2357 $358.7K (19.8%), and J3380 $311.1K (17.1%), indicating that a majority of Medicare dollars come from a small set of biologic products.

The code mix and descriptions point to a specialty infusion/injectable operation: J3245 (tildrakizumab), J2357 (omalizumab), and J3380 (vedolizumab) are high‑cost biologic injections and together with J1569 (immune globulin, $202.5K, 11.2%) and J1745 (infliximab, $159.4K, 8.8%) suggest routine administration of specialty biologics and immunoglobulin/infusion therapies rather than primary care office visits. This pattern is consistent with a practice model focused on in‑office administration of specialty drugs and infusion care.

Competitive standing varies by product: the provider ranks relatively high for omalizumab (J2357 is #53 of 581 nationally, 91th percentile) and vedolizumab (J3380 is #92 of 620 nationally, 85th percentile), indicating above‑typical national volume for those biologics, while J3245 (J3245 is #94 of 225 nationally, 56th percentile) is closer to typical peer volume. In short, the practice is a notable national participant for certain biologics (omalizumab and vedolizumab) but more modest for others.

There are statistically notable outliers in procedural injections: 96372 shows 646 claims for $5.8K revenue and is described as notably above typical national volume (rank #1028 of 58224, 98th percentile). This suggests frequent use of intramuscular or subcutaneous injections in clinic workflows, complementing the specialty biologic administration profile.

Infusion and chemotherapy administration codes appear but are a smaller portion of revenue, indicating some additional infusion throughput beyond the primary biologics: 96413 shows $19.6K (1.1% of Medicare revenue) and ranks #2530 of 7514 (66th percentile), and 96365 shows $8.6K (0.5%) and ranks #1621 of 8873 (82th percentile). These entries support the conclusion that the practice performs repeated infusion/administration procedures, but those services are secondary to high‑value biologic drug billing.

For payers and contract analysts, the combination of a Medicare‑dominant revenue base ($1.8M) and concentration in a few specialty biologic codes (61.7% of Medicare revenue from the top three) signals that reimbursement changes or shifts in biologic utilization could materially affect this provider’s revenue. The provider’s strong national percentile placement on certain biologics (e.g., J2357 and J3380) makes it a relevant counterpart for payer discussions specific to biologic/infusion coverage and reimbursement in the Blue Springs, MO market.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3245	Injection, tildrakizumab, 1 mg	4,100	$110	$451K
J2357	Injection, omalizumab, 5 mg	11,960	$30	$358.6K
J3380	Injection, vedolizumab, intravenous, 1 mg	18,300	$20	$311.1K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	5,620	$40	$202.5K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	6,130	$30	$159.4K
J0517	Injection, benralizumab, 1 mg	1,050	$130	$138.6K
J3032	Injection, eptinezumab-jjmr, 1 mg	6,400	$10	$83.2K
J1306	Injection, inclisiran, 1 mg	7,950	$10	$71.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	230	$80	$19.6K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	220	$40	$8.6K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Missouri Distribution

Patrick Jensen — 2 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Missouri

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3245	4	10	4,100	$110	$475.4K
J3380	8	20	10,800	$20	$280.1K
J1569	3	10	4,350	$40	$171.2K
J0517	3	10	1,070	$130	$147.2K
J2357	1	10	3,300	$30	$128.1K
J1745	10	40	3,060	$30	$118.1K
J3032	1	10	6,400	$10	$86.3K
J1306	3	10	6,530	$10	$61.5K
96413	48	160	140	$100	$19.1K
96365	22	210	40	$50	$4.4K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Patrick Jensen, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Rachel Beggs	MO	Nurse Practitioner	$1.4M	$0
Clare Roewe	KS	Family Nurse Practitioner	$952.9K	$0
Myranda Prather	KS	Family Nurse Practitioner	$692.8K	$0
Sarah Foster	MO	Family Nurse Practitioner	$675.5K	$0
Amy Carpenter	MO	Nurse Practitioner	$415.6K	$0
Robert Jackson	MO	Rheumatology Physician	$173.3K	$0
Breanna Muniz	KS	Family Nurse Practitioner	$153.2K	$0
Tonia Nerini	MO	Gerontology Nurse Practitioner	$8.2K	$0

Nearby Providers

Other providers in the same ZIP code as Patrick Jensen, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Rainbow Center For Communicative Disorders	MO	Developmentally Disabled Services Day Training Agency	$0	$11.1M
Lincare Inc.	MO	Durable Medical Equipment & Medical Supplies	$0	$8.8M
Impact Medical Services LLC	MO	Durable Medical Equipment & Medical Supplies	$0	$4.7M
Tara Skurat	MO	Nurse Practitioner	$269.5K	$0
Dana Sandusky	MO	Nurse Practitioner	$241.2K	$0
Hy-vee Inc	MO	Community/Retail Pharmacy	$215.7K	$0
Melissa Hildebrandt	MO	Family Nurse Practitioner	$184.1K	$0
Ann Hanon	MO	Foot & Ankle Surgery Podiatrist	$115.5K	$0
Jonathan Tolman	MO	Family Nurse Practitioner	$110K	$0
Vincent Demarco	MO	Family Medicine Physician	$103.7K	$0

Patrick Jensen — Billing Profile & Reimbursement Data

Sign up for Patrick Jensen — Billing Profile & Reimbursement Data policy alerts

Patrick Jensen — Billing Profile & Reimbursement Data

Sign up for Patrick Jensen — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References